Latest Divestments News

Arika Resources has launched an expanded 10,000m drilling campaign at its Yundamindra Gold Project and identified multiple new targets at Kookynie, backed by a $5 million capital raise. The company is poised for a busy second half of 2025 with assay results and further drilling on the horizon.

Bastion Minerals has resumed ASX trading under a refreshed leadership team, announcing a JORC-compliant resource at its ICE Copper-Gold Project and completing multiple capital raises to support its renewed exploration focus.

Great Boulder Resources reports a busy quarter with extensive drilling at Side Well and a robust scoping study at Ironbark, highlighting strong project economics and a recent $12.5 million capital raise.

Moho Resources has completed the sale of its Empress Springs Project, securing over $700,000 in cash inflows, while unveiling a significant new gold anomaly at its Silver Swan North Project in Western Australia.

Austin Metals reports promising gold and copper-gold drilling results at its Western Australian projects while divesting its Broken Hill assets to sharpen focus on core holdings.

Cullen Resources Limited reported significant progress across its gold exploration portfolio in Western Australia and Finland, including new project acquisitions and active joint venture drilling campaigns.

Mad Paws Holding Limited reported modest revenue growth and improved cash flow in Q4 2025, while progressing a significant acquisition deal with Rover Group and divesting its Pet Chemist business.

MedAdvisor Solutions reported a 16.6% revenue decline in 4Q FY25, driven by US market challenges, while completing the sale of its ANZ business and initiating a strategic review of its US operations.

MedAdvisor reports a significant revenue decline in FY25 amid US program delays but strengthens its balance sheet through a capital raise and ANZ business sale. The company signals a strategic pivot with potential US business divestment on the horizon.

Decidr AI Industries reported an 82% revenue jump in its AI platform during Q4 FY25, launched AI Mentors with The Growth Faculty, and divested its 13Seeds business to sharpen focus on AI innovation.

Janus Electric Holdings has relaunched on the ASX, securing $8.8 million to accelerate its heavy vehicle electrification strategy, including a key supply agreement with Electrovaya for next-generation lithium-ion batteries.

Neurotech International reports encouraging Phase I human pharmacokinetic results for its pediatric cannabinoid drug NTI164, alongside published clinical trial data in Rett Syndrome and key regulatory progress in the US and Australia.